Researchers of Bristol-Myers Squibb have developed a new drug for the treatment of cancer. The drug is known as Ipilimumab and besides skin cancer, it is claimed to be successful on prostate, liver, lung and brain tumors.

Dr. Renzo Canetta of Bristol-Myers Squibb has declared the drug as a medical landmark, which offers hope to millions of sufferers. He added that with the help of this drug, cancer treatment in future will be more successful.

The researchers carried out the trails of drug on a patient with advanced melanoma with a life expectancy of weeks. After the completion of the trails, the patient responded well to treatment and now, after six years she is back to normal.

Skin cancer is leading killer in both men and women in the UK and it claims the lives of 2,000 people in the country. A clinical trial of Ipilimumab was shown to extend life expectancy in patients from six months to three years and beyond. The trial results were presented to 2,000 of the world's leading cancer experts in Chicago.

In the next two months, Ipilimumab is set to be given approval by the European Medicines Association.